Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
Sanborn TA, Ebrahimi R, Manoukian SV, McLaurin BT, Cox DA, Feit F, Hamon M, Mehran R, Stone GW. Sanborn TA, et al. Circ Cardiovasc Interv. 2010 Feb 1;3(1):57-62. doi: 10.1161/CIRCINTERVENTIONS.109.896704. Epub 2010 Jan 26. Circ Cardiovasc Interv. 2010. PMID: 20118151 Clinical Trial.
Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
Sanborn TA, Tomey MI, Mehran R, Généreux P, Witzenbichler B, Brener SJ, Kirtane AJ, McAndrew TC, Kornowski R, Dudek D, Nikolsky E, Stone GW. Sanborn TA, et al. Catheter Cardiovasc Interv. 2015 Feb 15;85(3):371-9. doi: 10.1002/ccd.25663. Epub 2014 Oct 28. Catheter Cardiovasc Interv. 2015. PMID: 25179260 Clinical Trial.
Status of femoral closure devices.
Sanborn TA, Feldman T. Sanborn TA, et al. Am Heart Hosp J. 2003 Summer;1(3):212-5. doi: 10.1111/j.1541-9215.2003.02358.x. Am Heart Hosp J. 2003. PMID: 15785191 Review.
138 results